Your browser doesn't support javascript.
loading
Natalizumab treatment of multiple sclerosis - a Danish nationwide study with 13 years of follow-up.
Buron, Mathias Due; Christensen, Jeppe Romme; Pontieri, Luigi; Joensen, Hanna; Kant, Matthias; Rasmussen, Peter Vestergaard; Sellebjerg, Finn; Sørensen, Per Soelberg; Bech, Danny; Magyari, Melinda.
Affiliation
  • Buron MD; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Electronic address: mathias.buron@regionh.dk.
  • Christensen JR; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pontieri L; The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Joensen H; The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Kant M; MS clinic Southern Denmark, Department of Neurology, University of Southern Denmark, Hospital of Southern Jutland, Denmark.
  • Rasmussen PV; Department of Neurology, Aarhus University Hospital, Denmark.
  • Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Sørensen PS; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Bech D; Department of Neurology, Viborg Regional Hospital, Denmark.
  • Magyari M; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Mult Scler Relat Disord ; 74: 104713, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37058764

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Mult Scler Relat Disord Year: 2023 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Mult Scler Relat Disord Year: 2023 Document type: Article Country of publication: Países Bajos